'Il Sole 24 Ore' talks about DemBiotech® in an interview with journalist Barbara Ganza and our CEO Elena Sgaravatti.
"We have been using plant extracts for a long time but they have always had problems: first of all, their supply as they are often present in small quantities and only at certain times of the year; then quality and safety, because they are exposed to environmental contaminants that can be cut down but not completely, and the risk of adulteration is always possible. The active ingredients can come from rare and protected plants, and the great demand can cause incorrect behaviors. DemBiotech's CROP® platform overcomes these obstacles.
Read the article and find out how.